The international liquid biopsy sector is seeing substantial increase, driven by advancements in cancer detection and targeted treatment. Current estimates value the market revenue at approximately USD X.X billion in the current year, with expectations indicating a a estimated CAGR of Y.Z percent through 2030. Dominant trends include the increasing